Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
12:00 AM - 29th ECCMID
14
16
17
18
19
20
21
22
23
25
26
27
29
30
1
2
3
4
5
29th ECCMID
2019-04-13 - 2019-04-16    
All Day
Welcome to ECCMID 2019! We invite you to the 29th European Congress of Clinical Microbiology & Infectious Diseases, which will take place in Amsterdam, Netherlands, [...]
4th International Conference on  General Practice & Primary Care
2019-04-15 - 2019-04-16    
All Day
The 4th International Conference on General Practice & Primary Care going to be held at April 15-16, 2019 Berlin, Germany. Designation Statement The theme of [...]
Digital Health Conference 2019
2019-04-24 - 2019-04-25    
12:00 am
An Innovative Bridging for Modern Healthcare About Hosting Organization: conference series llc ltd |Conference Series llc ltd Houston USA| April 24-25,2019 Conference series llc ltd, [...]
International Conference on  Digital Health
2019-04-24 - 2019-04-25    
All Day
Details of Digital Health 2019 conference in USA : Conference Name                              [...]
16th Annual World Health Care Congress -WHCC19
2019-04-28 - 2019-05-01    
All Day
16th Annual World Health Care Congress will be organized during April 28 - May 1, 2019 at Washington, DC Who Attends Hospitals, Health Systems, & [...]
Events on 2019-04-13
29th ECCMID
13 Apr 19
Amsterdam
Events on 2019-04-24
Events on 2019-04-28
Blog Latest News

Global Cancer Tumor Profiling Market Growth by Regions, Technology and Analysis of Key Players

The demand for cancer profiling methods has witnessed significant growth over the years with seamlessly integrating next-generation sequencing (NGS) and in-situ hybridization for cancer profiling. In addition, cancer profiling for the detection of molecular & genetic level of cancers, and use of personalized and targeted approaches for treatment have propelled the market growth.

The Global Cancer Tumor Profiling Market  accounted to USD 25,318 million in 2016 growing at a CAGR of 18.3% during the forecast period of 2017 to 2024.

The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The potential of cancer profiling is extended from common cancers such as lymphoma and breast cancer to molecular profiling of lung cancer, prostate cancer and acute leukemia.

No. of Report Pages: 350

Request for Free Sample of Global Cancer Tumor Profiling Market Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-tumor-profiling-market

Major Market Drivers and Restraints:

  • Technological advancements for identifying the cancer tumors.
  • Increasing the cancer incidences.
  • Increase in the use of biomarkers in tumor profiling.
  • Availability of Funding for Cancer Research
  • Increase in demand for next generation sequencing technique in cancer profiling.
  • Lack of Skilled Professionals and Infrastructure
  • Growth in demand of personalized medicines

Browse Full Detailed with TOC, Sample, Inquiry, Expert and Global Cancer Tumor Profiling Market Visit @ http://databridgemarketresearch.com/reports/global-cancer-tumor-profiling-market/

Market Segmentation by Types

By Technique the market is segmented in

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

By Application the market is segmented into

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Research applications

On the basis of geography, global cancer tumor profiling market report covers data points for 28 countries across multiple geographies such as

  • North America & South America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Top Key Players are:

tareIllumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, NeoGenomics Laboratories, Inc., HTG Molecular Diagnostics, Inc., Genomic Health Inc. , Caris Life Sciences, Helomics Corp., NanoString Technologies, Inc., Oxford Gene Technology, Abbott, BD, Hologic, Inc., Siemens Medical Solutions USA, Inc., Personal Genome Diagnostics, Inc., FOUNDATION MEDICINE, INC., Contextual Genomics, AGENDIA, Perthera, Inc., ApoCell, GenScript, Ribomed, Boreal Genomics Inc., Biotheranostics and Proteome Sciences among others.

For Any Query Speak to Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cancer-tumor-profiling-market

Related Report

Global Computed Tomography Devices Market – Industry Trends and Forecast to 2024

Global Computed Tomography Devices Market, By product (Low Slice CT Scanner, Medium Slice CT Scanner, High Slice CT Scanner), by Application (Cardiovascular, Oncology, Neurovascular, Abdomen and Pelvic, Pulmonary Angiogram, Spinal, Musculoskeletal), by End-User (Hospitals, Diagnostics Centers), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Access Report: http://databridgemarketresearch.com/reports/global-computed-tomography-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sales@databridgemarketresearch.com

Investor: investors@databridgemarketresearch.com

Visit Blog: http://databridgemarketresearch.com/blog/

Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research